MAC
LLY icon

Mason & Associates (California)’s Eli Lilly LLY Stock Holding History

Mason & Associates (California)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
963
+20
+2% +$20.4K 0.19% 62
2026
Q1 		$836K Hold
943
– – 0.16% 71
2025
Q4 		$1.01M Sell
943
-239
-20% -$229K 0.19% 62
2025
Q3 		$902K Buy
1,182
+299
+34% +$223K 0.18% 52
2025
Q2 		$688K Hold
883
– – 0.16% 65
2025
Q1 		$729K Sell
883
-24
-3% -$20K 0.18% 57
2024
Q4 		$700K Sell
907
-15
-2% -$12.4K 0.16% 61
2024
Q3 		$817K Buy
922
+113
+14% +$102K 0.2% 55
2024
Q2 		$732K Buy
809
+448
+124% +$358K 0.19% 52
2024
Q1 		$281K Buy
+361
New +$257K 0.07% 89

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mason & Associates (California)'s LLY Position: Q2 2026 in Review

Mason & Associates (California) increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 963 shares worth $1.16M. The position accounts for 0.19% of the portfolio, ranked #62.

Mason & Associates (California) first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mason & Associates (California) held 963 shares of Eli Lilly worth $1.16M as of Q2 2026.
  • Mason & Associates (California) bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.19% of Mason & Associates (California)'s portfolio in Q2 2026, its #62 holding.
  • Mason & Associates (California) first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mason & Associates (California)'s 13F filing for Q2 2026, filed 23 Jul 2026.